期刊文献+

缬沙坦和阿托伐他汀治疗高血压合并持续性心房颤动疗效研究 被引量:6

下载PDF
导出
摘要 目的研究缬沙坦联合阿托伐他汀治疗高血压合并持续性心房颤动的疗效。方法将108例高血压合并持续性心房颤动患者随机分为治疗组(缬沙坦+阿托伐他汀)和对照组(阿托伐他汀),进行为期18个月的持续观察。结果缬沙坦联合阿托伐他汀在降低三酰甘油、总胆固醇、低密度脂蛋白胆固醇、超敏C反应蛋白、左心房内径和左室质量指数等方面疗效显著。结论缬沙坦联合阿托伐他汀治疗高血压合并持续性心房颤动效果良好。
作者 吴建国
出处 《检验医学与临床》 CAS 2013年第12期1590-1591,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献9

  • 1刘力生,王文,姚崇华.2009年基层版《中国高血压防治指南》(摘录)[J].柳州医学,2011,24(2):104-117. 被引量:11
  • 2戚文航.血管紧张素受体拮抗剂与心房颤动[J].中华心血管病杂志,2004,32(11):1042-1043. 被引量:93
  • 3Blender S,Gerstenfeld EP,Lin Dv et al. Ablation of atrial fibrillation: localizing triggers, mapping systems and abla?tion techeniques[J]. Minerva Cardioangiol , 2004,52 (2) : 95-109.
  • 4Gosselink ATM, Smith AJ, Crijn CJ , et al. Alteration of peripheral vasodilatory reservecapacity after cardioversion of atrial fibrilation[J]. Eur HeartJ, 1996, 17 (8): 926- 934.
  • 5van Wagoner DR. Oxidative stress and inflammation in at?rial fibrillation: raid in pathogenesis and potential as a therapeutic target[J].J Cardiovasc Pharmacol, 2008,52 (4) :306-313.
  • 6Kourliouros A,Savelieva I, Kiotsekoglou A,et al. Current concepts in the pathogenesis of atrial fibrillation[J]. Am HeartJ ,2009,157(2) :243-252.
  • 7Skalidis ElvZacharis EA, Tsetis DK,et al. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm[J]. AmJ Cardiol,2007 ,99(9): 1258-1262.
  • 8Guazzi M, Berti M, Belletti S, et al. Exercise metaboreflex activation and endothelial function impairment in atrial fi?brillation[J]. AmJ Physiol Heart Circ Physiol , 2006,291 (5) : 2396-2402.
  • 9Adam O,Neuberger HR,Bohm M,et al. Prevention of at?rial fibrillation with 3-hydraxy-3-methylglutaryl coenzyme A reductase inhibitors[J]. Circulation, 2008, 118 (12): 1285-1293.

共引文献102

同被引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部